Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
Reed Magleby, Lars F. Westblade, Alex Trzebucki, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e4197-e4205
Open Access | Times Cited: 404

Showing 1-25 of 404 citing articles:

Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 3, pp. 238-251
Open Access | Times Cited: 1693
Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski, Martin Sebastian Winkler, Tomasz Skirecki, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 622-642
Open Access | Times Cited: 475
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz, et al.
Science Immunology (2020) Vol. 5, Iss. 54
Open Access | Times Cited: 469
Role of favipiravir in the treatment of COVID-19
Shashank Joshi, Jalil Parkar, Abdul Samad Ansari, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 501-508
Open Access | Times Cited: 422
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1319-1368
Open Access | Times Cited: 361
The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis
Karla Romero Starke, David Reissig, Gabriela Petereit-Haack, et al.
BMJ Global Health (2021) Vol. 6, Iss. 12, pp. e006434-e006434
Open Access | Times Cited: 289
Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers
Youley Tjendra, Abdulaziz F. Al Mana, Andrea P. Espejo-Freire, et al.
Archives of Pathology & Laboratory Medicine (2020) Vol. 144, Iss. 12, pp. 1465-1474
Open Access | Times Cited: 240
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
Lars F. Westblade, Gagandeep Brar, Laura C. Pinheiro, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 661-671.e2
Open Access | Times Cited: 229
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
Nadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 8
Open Access | Times Cited: 218
Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids
Pratik Sinha, David Furfaro, Matthew J. Cummings, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 204, Iss. 11, pp. 1274-1285
Open Access | Times Cited: 193
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19
Ali A. Rabaan, Raghavendra Tirupathi, Anupam Sule, et al.
Diagnostics (2021) Vol. 11, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 191
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 164
College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value
Daniel D. Rhoads, David R. Peaper, Rosemary C. She, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 10, pp. e685-e686
Closed Access | Times Cited: 163
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2174-2188.e5
Open Access | Times Cited: 161
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 151
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
Imran Sulaiman, Matthew Chung, Luis F. Angel, et al.
Nature Microbiology (2021) Vol. 6, Iss. 10, pp. 1245-1258
Open Access | Times Cited: 148
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
Claudia Alteri, Valeria Cento, Antonio Piralla, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 119
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
Steven Lim, Chee Peng Hor, Kim Heng Tay, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 4, pp. 426-426
Open Access | Times Cited: 89
Multiplexed reverse-transcriptase quantitative polymerase chain reaction using plasmonic nanoparticles for point-of-care COVID-19 diagnosis
Nicole R. Blumenfeld, Michael Anne E. Bolene, Martin Jaspan, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 9, pp. 984-992
Open Access | Times Cited: 68
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
David S. Khoury, Adam K. Wheatley, Mitchell D. Ramuta, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 727-738
Open Access | Times Cited: 122
Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19
Guohui Xue, Xing Gan, Zhìqiáng Wú, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107065-107065
Open Access | Times Cited: 104
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
Stefanie Deinhardt‐Emmer, Daniel Wittschieber, Juliane Sanft, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 99
Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection
Helena C. Maltezou, Vasilios Raftopoulos, Rengina Vorou, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 7, pp. 1132-1138
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top